Mainz Biomed announces live launch of ColoAlert with Bioclinica in Romania

Mainz Biomed announces the live launch of Mainz Biomed’s flagship product, ColoAlert – a highly effective and user-friendly at-home detection test for colorectal cancer – with strategic partner Bioclinica, a national leader in the Romanian healthcare sector. This partnership signifies a pivotal step towards enhancing healthcare outcomes in the country through advanced diagnostics. The collaboration with Bioclinica adds significant value to Mainz Biomed’s mission. Leveraging the renowned expertise and extensive network of Bioclinica, ColoAlert will immediately become available to a large portion of the Romanian population “We are delighted to see ColoAlert now made available to Romanian’s through our key partnership with Bioclinica,” commented Darin Leigh, Chief Commercial Officer of Mainz Biomed. “Our collaboration demonstrates a shared commitment to introducing state-of-the-art diagnostic solutions that can have a transformative impact on public health. Early detection is paramount in combating diseases like colorectal cancer, and our collaboration with Bioclinica exemplifies our mission to ensure more people globally have access to diagnostic tests that can give them a life-changing headstart on this disease.”